Acorda Therapeutics, Inc. Royalty Expense
Acorda Therapeutics, Inc. reported Royalty Expense of $5.70 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2012-02-28
- Acorda Therapeutics, Inc. royalty expense for the quarter ending 2011-09-30 was $1.10M.
- Acorda Therapeutics, Inc. royalty expense for fiscal 2010 was $6.90M.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2011-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $5.70M 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | $4.60M 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $6.90M 10-K · filed 2012-02-28 |